• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于“组学”反应的贝叶斯基因集基准剂量估计

Bayesian gene set benchmark dose estimation for "omic" responses.

作者信息

Zilber Daniel, Messier Kyle P, House John, Parham Fred, Auerbach Scott S, Wheeler Matthew W

机构信息

Division of Intramural Research, Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.

Division of Translational Toxicology, Predictive Toxicology Branch, National Institute of Environmental Health Sciences, Durham, NC 27713, United States.

出版信息

Bioinformatics. 2024 Dec 26;41(1). doi: 10.1093/bioinformatics/btaf008.

DOI:10.1093/bioinformatics/btaf008
PMID:39786864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11783320/
Abstract

MOTIVATION

Estimating a toxic reference point using tools like the benchmark dose (BMD) is a critical step in setting policy to regulate pollution and ensure safe environments. Toxicity can be measured for different endpoints, including changes in gene expression and histopathology for various tissues, and is typically explored one gene or tissue at a time in a univariate setting that ignores correlation. In this work, we develop a multivariate estimation procedure to estimate the BMD for specified gene sets. Our approach extends the foundational univariate approach by accounting for correlation in a statistically principled way.

RESULTS

We illustrate the method using data from a 5-day rat study and Hallmark gene sets and compare to existing BMD results computed by the EPA for both gene sets and apical histopathology endpoints. In contrast to previous ad-hoc methods, our principled approach provides the needed extension to bring the foundational univariate method into the multivariate world of transcriptomics. In addition to use in a regulatory setting, our method can provide hypothesis generation when gene sets correspond to mechanistic pathways.

AVAILABILITY AND IMPLEMENTATION

BS-BMD is implemented in R and C++ and available at https://github.com/NIEHS/BS-BMD.

摘要

动机

使用基准剂量(BMD)等工具来估计毒性参考点,是制定污染监管政策和确保环境安全的关键步骤。毒性可以针对不同的终点进行测量,包括各种组织的基因表达变化和组织病理学变化,并且通常在忽略相关性的单变量设置中一次研究一个基因或组织。在这项工作中,我们开发了一种多变量估计程序,用于估计特定基因集的BMD。我们的方法通过以统计上合理的方式考虑相关性,扩展了基础单变量方法。

结果

我们使用来自一项为期5天的大鼠研究的数据和标志性基因集来说明该方法,并与美国环境保护局(EPA)针对基因集和顶端组织病理学终点计算的现有BMD结果进行比较。与以前的临时方法不同,我们的合理方法提供了必要的扩展,将基础单变量方法带入转录组学的多变量领域。除了用于监管环境外,当基因集对应于机制途径时,我们的方法还可以提供假设生成。

可用性和实现

BS - BMD用R和C++实现,可在https://github.com/NIEHS/BS-BMD获取。

相似文献

1
Bayesian gene set benchmark dose estimation for "omic" responses.用于“组学”反应的贝叶斯基因集基准剂量估计
Bioinformatics. 2024 Dec 26;41(1). doi: 10.1093/bioinformatics/btaf008.
2
A Web-Based System for Bayesian Benchmark Dose Estimation.基于网络的贝叶斯基准剂量估计系统。
Environ Health Perspect. 2018 Jan 11;126(1):017002. doi: 10.1289/EHP1289.
3
A computational system for Bayesian benchmark dose estimation of genomic data in BBMD.贝叶斯基准剂量基因组数据计算系统在 BBMD 中的应用。
Environ Int. 2022 Mar;161:107135. doi: 10.1016/j.envint.2022.107135. Epub 2022 Feb 9.
4
Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.连续数据的模型不确定性与贝叶斯模型平均基准剂量估计
Risk Anal. 2014 Jan;34(1):101-20. doi: 10.1111/risa.12078. Epub 2013 Jun 11.
5
Metabolomics Simultaneously Derives Benchmark Dose Estimates and Discovers Metabolic Biotransformations in a Rat Bioassay.代谢组学同时推导出基准剂量估计值,并在大鼠生物测定中发现代谢生物转化。
Chem Res Toxicol. 2024 Jun 17;37(6):923-934. doi: 10.1021/acs.chemrestox.4c00002. Epub 2024 Jun 6.
6
Part 1. Statistical Learning Methods for the Effects of Multiple Air Pollution Constituents.第1部分. 多种空气污染成分影响的统计学习方法
Res Rep Health Eff Inst. 2015 Jun(183 Pt 1-2):5-50.
7
Quantitative Risk Assessment: Developing a Bayesian Approach to Dichotomous Dose-Response Uncertainty.定量风险评估:建立二项剂量反应不确定性的贝叶斯方法。
Risk Anal. 2020 Sep;40(9):1706-1722. doi: 10.1111/risa.13537. Epub 2020 Jun 29.
8
Considerations for application of benchmark dose modeling in radiation research: workshop highlights.应用基准剂量建模在辐射研究中的考虑因素:研讨会要点。
Int J Radiat Biol. 2023;99(9):1320-1331. doi: 10.1080/09553002.2023.2181998. Epub 2023 Mar 7.
9
A comparison of three methods for integrating historical information for Bayesian model averaged benchmark dose estimation.三种方法用于贝叶斯模型平均基准剂量估计中整合历史信息的比较。
Environ Toxicol Pharmacol. 2012 Sep;34(2):288-296. doi: 10.1016/j.etap.2012.05.002. Epub 2012 May 14.
10
Benchmarking algorithms for spatially variable gene identification in spatial transcriptomics.空间转录组学中空间可变基因识别的基准测试算法
Bioinformatics. 2025 Mar 29;41(4). doi: 10.1093/bioinformatics/btaf131.

引用本文的文献

1
Modeling omics dose-response at the pathway level with DoseRider.使用DoseRider在通路水平上对组学剂量反应进行建模。
Comput Struct Biotechnol J. 2025 Apr 3;27:1440-1448. doi: 10.1016/j.csbj.2025.04.004. eCollection 2025.

本文引用的文献

1
From vision toward best practices: Evaluating transcriptomic points of departure for application in risk assessment using a uniform workflow.从愿景到最佳实践:使用统一工作流程评估转录组学出发点以应用于风险评估
Front Toxicol. 2023 May 23;5:1194895. doi: 10.3389/ftox.2023.1194895. eCollection 2023.
2
The Gene Ontology knowledgebase in 2023.2023 版基因本体论知识库。
Genetics. 2023 May 4;224(1). doi: 10.1093/genetics/iyad031.
3
Latent Variables Capture Pathway-Level Points of Departure in High-Throughput Toxicogenomic Data.潜在变量捕获高通量毒理基因组学数据中的途径起始点。
Chem Res Toxicol. 2022 Apr 18;35(4):670-683. doi: 10.1021/acs.chemrestox.1c00444. Epub 2022 Mar 25.
4
tcplfit2: an R-language general purpose concentration-response modeling package.tcplfit2:一个 R 语言通用浓度反应建模包。
Bioinformatics. 2022 Jan 27;38(4):1157-1158. doi: 10.1093/bioinformatics/btab779.
5
High-Throughput Transcriptomics Platform for Screening Environmental Chemicals.高通量转录组学平台用于筛选环境化学物质。
Toxicol Sci. 2021 Apr 27;181(1):68-89. doi: 10.1093/toxsci/kfab009.
6
Comparison of Approaches for Determining Bioactivity Hits from High-Dimensional Profiling Data.从高维分析数据中确定生物活性命中的方法比较。
SLAS Discov. 2021 Feb;26(2):292-308. doi: 10.1177/2472555220950245. Epub 2020 Aug 29.
7
Evaluation of 5-day In Vivo Rat Liver and Kidney With High-throughput Transcriptomics for Estimating Benchmark Doses of Apical Outcomes.高通量转录组学评价大鼠 5 天体内肝、肾,用于估算顶极终点的基准剂量。
Toxicol Sci. 2020 Aug 1;176(2):343-354. doi: 10.1093/toxsci/kfaa081.
8
Fibrate pharmacogenomics: expanding past the genome.纤维酸类药物遗传学:超越基因组。
Pharmacogenomics. 2020 Mar;21(4):293-306. doi: 10.2217/pgs-2019-0140. Epub 2020 Mar 17.
9
Pathway-level information extractor (PLIER) for gene expression data.用于基因表达数据的通路级别信息提取器(PLIER)。
Nat Methods. 2019 Jul;16(7):607-610. doi: 10.1038/s41592-019-0456-1. Epub 2019 Jun 27.
10
The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration Modeling.决议的力量:使用高通量转录组学和基准浓度建模对肝损伤化学物质的生物学反应进行语境化理解。
Toxicol Sci. 2019 Jun 1;169(2):553-566. doi: 10.1093/toxsci/kfz065.